1. Biomedical Poster Tour (18:15 start)
Chair: Joyce Wilson
18:15-18:25: Impact of Chronic HCV Infection on CD4 T-Cell Permissiveness to HIV Infection and Viral Reservoir Persistence, Samaa T. Gobran Poster No: P-035
18:25-18:35: Investigating the Mechanism of NS5A-Mediated Viral Replication Organelle Biogenesis, Michelle Manolya Sag Poster No: P-034
18:35-18:45: Hedgehog Signalling Mediates Interferon-Gamma Production, Supporting Gene Expression Signatures of Metabolic Dysfunction in Activated CD8+ T Cells in HCV Infection with Advanced Liver Fibrosis, Jeff Li Poster No: P-030
Clinical Poster Tour (18:45 start)
Chair: Alexandra King
18:45-18:55: Leveraging COVID-19 Vaccination to Enhance HCV Testing in Priority Populations, Aaron Vanderhoff Poster No: P-01
18:55-19:05: Impact of COVID-19 on Epic: Evaluation of Pharmacy-Based Identification and Treatment of Hepatitis C in Victoria, British Columbia, Chris Fraser Poster No: P-023
19:05-19:15: Hepatic Decompensation and Hepatocellular Carcinoma After Stopping Nucleos(T)ide Analogue Therapy: Results from a Large, Global, Multi-Etchnic Cohort of Patients with Chronic Hepatitis B (Retract-B Study), Grishma Hirode Poster No: P-012
19:15 – Poster Tour Completed
2. Population Health Research Poster Tour (18:15 start)
Chair: William Wong
18:15-18:25: The Hepatitis C Care Cascade in Immigrant and Non-Immigrants in Quebec: a Population-Based Study, Ana Maria Passos-Castilho Poster No: P-040
18:25-18:35: Validation of Case-Ascertainment Algorithms to Identify People Who Inject Drugs in Health Administrative Data in Ontario, Zoë Greenwald Poster No: P-067
18:35-18:45: Chronic Pain, Substance Use, HCV and Other Related Harms in a Longitudinal Cohort of People who Inject Drugs in Montreal: Study Protocol, Sasha Udhesister Poster No: P-064
Health Services Research Poster Tour (18:45 start)
Chair: Mia Biondi
18:45-18:55: Universal Hepatitis C Prenatal Screening, Subsequent Testing, and Linkage to Care at a Tertiary Care Centre in Ontario, Mia Biondi Poster: No P059
18:55-19:05: Determining the Barriers and Enablers to Hepatitis C Antibody Screening and RNA Testing in Needle Syringe Programs: Preliminary Findings of the Hepcast Theory-Informed Qualitative Study with People who Inject Drugs, Guillaume Fontaine Poster No : P-050
19:05-19:15: Gender, Incarceration and Cocaine Use: Barriers to HCV Treatment Uptake Persist for People Who Inject Drugs Despite Universal Coverage of Direct-Acting Antiviral Agents, Nathalie Jiang Poster No: P-062
19:15 – Poster Tour Completed